Delivery Order SPE2DB22D1106-SPE2DB24FEBD2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mL vials of 0.5% Tetracaine sterile solution. The $3,019.24 contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The Defense Logistics Agency awarded a $2,094.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4-milliliter units. The contract, which represents a child award under AmerisourceBergen's larger federal contract vehicle, is scheduled for completion by September 4, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of tetracaine 0.5% eye solution. The contract has a ceiling value of $1,950.60 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, delivering pharmaceutical products and medical supplies to support military treatment...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units. This contract, valued at $3,539.90, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is classified as a child contract and executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Tetracaine 0.5% Steri-Unit Solution, 4 mL, with a potential value of $1,221.04. The order has a completion date of January 23, 2024 and was awarded on January 22, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,626.78, is for the provision of 0.5% Tetracaine Steri-Unit Solution in 4 mL vials. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of tetracaine 0.5% steri-unit solution (4 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,941.72 firm fixed price delivery order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,988,146 units of 0.5% Tetracaine Steri-Unit Solution (4 mL). The contract has an ultimate completion date of March 18, 2024 and a ceiling value of $3,087.08. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units, with a ceiling value of $3,441.49. This firm fixed-price delivery order, which is not subject to any set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract vehicle, designated SPE2DX, is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,575.01 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4mL units, with an ultimate completion date of October 23, 2025. This firm fixed-price contract, awarded on October 22, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEBD2Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract provides the supply of Tetracaine 1% (20 mg/2 ml) medical vials, with a potential value of $2,321.22 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 2/21/24 |